Skip to main content

Find Clinical Trials

Home
Conditions
Malignant Glioma

Clinical trial condition

Malignant Glioma

Explore clinical trials studying Malignant Glioma. Study availability and eligibility vary by location and protocol.

121 public trials 13 recruiting studies

Refine in advanced search Browse all conditions

Malignant Glioma trial results

Completed

Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas

NCT00528684

Conditions: Astrocytoma, Glioblastoma, Glioma, +8 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Cedars-Sinai Medical Center Los Angeles, California, United States

The Ohio State University Medical Center and Arthur G. James Cancer Hospital and Richard J. Solove Research Center Columbus, Ohio, United States

View Trial Details

Completed

Radiosurgery and Avastin for Recurrent Malignant Gliomas

NCT01017250

Conditions: Disease Attributes, Glioma, Malignant Glioma, +10 more
Locations: Duke University Medical Center, Radiation Oncology Durham, North Carolina, United States

View Trial Details

Completed

Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme

NCT00919737

Conditions: Glioma, Malignant Glioma, Neoplasms, +6 more
Locations: The Tazuke Kofukai Foundation Medical Research Kitano Hospital Osaka, Japan

View Trial Details

Completed

Bevacizumab Plus Irinotecan Plus Carboplatin for Recurrent Malignant Glioma (MG)

NCT00953121

Conditions: Glioma, Malignant Glioma, Neoplasms, +6 more
Locations: Duke University Health System Durham, North Carolina, United States

View Trial Details

Completed

Study of Capecitabine to Treat Recurrent High Grade Gliomas

NCT00717197

Conditions: Astrocytoma, Glioblastoma, Glioma, +9 more
Locations: University of Florida Gainesville, Florida, United States

View Trial Details

Completed

Surgical Resection With Gliadel Wafer Followed by Dendritic Cells Vaccination for Malignant Glioma Patients

NCT00576446

Conditions: Glioma, Malignant Glioma, Neoplasms, +6 more
Locations: Cedars Sinai Medical center Los Angeles, California, United States

View Trial Details

Completed

Study of NPC-07 for Fluorescence-guided Resection of Malignant Gliomas

NCT01167322

Conditions: Glioma, Malignant Glioma, Neoplasms, +6 more
Locations: International Medical Center, Saitama Medical University Hidaka, Saitama, Japan

National Cancer Center Hospital Chuo-ku, Tokyo, Japan

Kyorin University Hospital Mitaka, Tokyo, Japan

View Trial Details

Completed

Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients

NCT00024557

Conditions: Anaplastic Astrocytoma, Astrocytoma, Disease Attributes, +16 more
Locations: University of California San Francisco San Francisco, California, United States

Yale University New Haven, Connecticut, United States

Memorial Sloan-Kettering Cancer Center New York, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma

NCT00064779

Conditions: Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Astrocytoma, +20 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma

NCT00041587

Conditions: Anaplastic Astrocytoma, Astrocytoma, Glioblastoma, +11 more
Locations: University of Colorado Health Sciences Center Denver, Colorado, United States

Cleveland Clinic Foundation Cleveland, Ohio, United States

University Hospital Eppendorf Hamburg, Germany

University Hospital Kiel, Department of Neurosurgery Kiel, Germany

View Trial Details